Saudi International Conference on Blood Transfusion

REGISTRATION
REGISTRATION

Session topics

  • Home
  • Session topics
Welcome to

Genomics in Transfusion Medicine

Goal and Objective

This session will explore the latest advancements in genomics as they relate to transfusion medicine. Participants will engage with cutting-edge genomic techniques and their applications in transfusion practices.

The session Learning Objectives:

  • Provide an overview of emerging blood group systems and their clinical significance.
  • Present strategies for HLA genotyping aimed at optimizing platelet matching and minimizing refractoriness.
  • Highlight the methodologies, outcomes, and potential benefits of using NIPT for RHD screening, based on experiences from Saudi Arabia.

By achieving these objectives, participants will gain a comprehensive understanding of the diverse applications of genomics in transfusion medicine, along with practical knowledge and strategies to implement in their respective practices.

Best Practices in Blood Donation

Goal and Objective

This session will cover 3 aspects of blood donation processes that require further attention on several levels. Blood banks face significant challenges when faced with patients who require rare donors because of the presence of multiple red cell antibodies or antibodies against a high prevalence antigen. The Kuwaiti rare donor program was established many years ago and the associated immunohematology reference laboratory is AABB accredited. The first speaker will share the experience of Kuwait in establishing the program in an applicable manner. The second speaker will share his personal experience as an avid user of various tools of artificial intelligence in many aspects of professional life. The lecture will focus on use of AI in blood donor management. The 3rd lecture will be given by a university faculty who specialized in marketing and customer service. Sharing experience from the business side, there are many lessons that will be shared with the audience on understanding and improving the blood donor experience.

Learning Objectives:

  • Describe the requirements for establishing a rare blood donor program
  • Identify artificial intelligence tools that can be utilized in donor management
  • Apply best practices to enhance the blood donor experience

Updates and Local Experience on Patient Blood Management

Goal and Objective

The session will explore cutting-edge advancements in patient blood management that are reshaping practices globally and locally. Participants will engage with insights aimed at fostering a collaborative approach while addressing challenges unique to different healthcare environments.

The session Learning Objectives:

  • Provide an overview of recent guidelines in patient blood management.
  • Highlight the significance of evidence-based strategies in optimizing blood use and improving patient outcomes.
  • Examine local initiatives that demonstrate effective implementation of patient blood management protocols.
  • Facilitate an exchange of ideas and challenges encountered in diverse healthcare settings to identify actionable solutions for the continuous enhancement of patient care.

By achieving these objectives, participants will leave the session with an understanding of the global and local landscape of patient blood management, enriched with practical knowledge and strategies to apply within their respective practices.

Innovations and Emerging Technologies in Blood Banking and Transfusion Medicine

Goal and Objective

Session Goals:

  • To examine recent scientific and technological advancements in blood banking and transfusion practices.
  • To address regulatory and policy considerations for the integration of novel technologies and methodologies.
  • To present global perspectives, updates, and key learnings from international implementation of blood bank innovations.

Learning Objectives:
By the conclusion of this session, participants will be able to:

  1. Describe recent innovations and technological developments in blood banking and transfusion medicine.
  2. Explain the scientific principles, clinical relevance, and patient care benefits associated with the implementation of these new technologies.
  3. Critically evaluate the ethical, regulatory, and operational implications of adopting emerging innovations in blood banking and transfusion services.

Biotherapies and Cell-Based Treatments: Advances and Applications

Goal and Objective

  • To explore cutting-edge innovations and laboratory integration of cell-based therapies and genome editing technologies.
  • To highlight regulatory and clinical challenges in implementing cell and gene therapies (CGT).
  • To examine best practices in clinical monitoring and local production of CAR-T cell therapies.
  • To share real-world insights from the journey of localizing CAR-T cell manufacturing in the region.
  • To foster interdisciplinary discussion to enhance safe, effective, and harmonized use of cellular therapies in healthcare.

Session Objectives:

By the end of this session, participants will be able to:

  1. Describe clinical and laboratory workflows for CRISPR-Cas genome editing platforms and their therapeutic applications.
  2. Identify regulatory considerations and strategies for harmonizing CGT implementation across different healthcare systems.
  3. Explain the principles of clinical monitoring and laboratory support for CAR-T cell therapy.
  4. Analyze the challenges and milestones encountered in the local manufacturing and implementation of CAR-T cell products.
  5. Engage in critical discussion regarding ethical, regulatory, and technical aspects of advanced cellular therapies.
  6. Recognize the contributions of experts and promote continuous learning in the field of biotherapies.

Clinical Transfusion Medicine

Goal and Objective

This session will explore key aspects of clinical transfusion, focusing on optimizing patient outcomes through evidence-based practices and innovative strategies. The session will explore the latest advancements in the use of blood components, appropriate transfusion alternatives, and techniques to minimize transfusion risks. The session will address the complexities of managing transfusions in diverse patient populations, such as pediatric and neonatal, and individuals with specific hematological conditions..

The session Learning Objectives:

  • Provide an overview of recent guidelines and best practices in clinical transfusion.
  • Emphasize the importance of evidence-based strategies in optimizing blood component utilization and enhancing patient outcomes in transfusion medicine.
  • Examine innovative local initiatives that demonstrate effective implementation of advanced clinical transfusion protocols.
  • Facilitate an exchange of ideas and challenges encountered in managing transfusions across diverse patient populations to identify actionable solutions for the continuous enhancement of patient care.

“By achieving these objectives, participants will leave the session with a comprehensive understanding of the global and local landscape of clinical transfusion, enriched with practical knowledge and strategies to apply within their respective practices.”

Reimagining Quality: Beyond Compliance in Blood Banking

Quality in blood banking is no longer a checklist of tasks—it’s a dynamic, strategic framework that connects every process to patient outcomes on a global scale. This session explores how modern blood services are embracing Quality 4.0, where digital transformation, automation, and data-driven insights converge to reshape traditional quality models. Success now depends not only on technology but also on embedding auditing as an active tool for driving continuous improvement and accountability. Leadership plays a critical role, with medical directors and operational teams working together to design quality into every layer of the system, ensuring safety, efficiency, and readiness for future challenges. Participants will discover how this integrated approach—blending innovation, structured evaluation, and leadership—delivers a resilient, forward-looking quality ecosystem in transfusion medicine.